In addition, serum IL-6 is elevated in SCLC in relationship with advanced stages, worse prognosis and Neuron Specific Enolase (NSE) levels, suggesting a possible role of IL-6 in SCLC progression [31], similarly to other cancers [32]. Here, ENO2 is linked to cancer.